Medicine and Dentistry
Infection
100%
Toxoplasma gondii
100%
Mitogen Activated Protein Kinase Inhibitor
100%
Encephalitozoonosis
100%
Mitogen Activated Protein Kinase P38
100%
Parasite (Microbiology)
66%
Mitogen Activated Protein Kinase P38 Inhibitor
66%
In Vitro
33%
Mitogen-Activated Protein Kinase
33%
Drug Action
33%
Fibroblast
33%
Intracellular Parasite
33%
4 (4 Fluorophenyl) 2 (4 Hydroxyphenyl) 5 (4 Pyridyl)imidazole
33%
Microsporidia
33%
Antiparasitic Activity
33%
SB 203580
33%
Encephalitozoon Cuniculi
33%
Sulfadiazine
33%
Immunosuppressive Treatment
33%
Pyrimethamine
33%
Keyphrases
Kinase Activation
100%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
100%
Encephalitozoon Cuniculi
100%
Toxoplasma Gondii (T. gondii)
100%
Mitogen-activated Protein Kinase Inhibitor
50%
Pyridinylimidazoles
33%
P38 Mitogen-activated Protein Kinase Inhibitor
33%
T. Gondii Infection
33%
Inoculum
16%
Mitogen-activated Protein Kinase
16%
Immunosuppression
16%
Antiparasitic
16%
Novel Class
16%
SB203580
16%
Pyrimethamine
16%
Improved Survival
16%
Imidazopyrimidine
16%
SB202190
16%
Sulfadiazine
16%
Human Fibroblasts
16%
Microsporidium
16%
Selective Agents
16%
Replication in Vitro
16%
Intracellular Parasites
16%
Drug Action
16%
Anti-Toxoplasma
16%
Protective Immunity
16%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse
100%
Mitogen Activated Protein Kinase P38
100%
Toxoplasma gondii
100%
Encephalitozoonosis
100%
Infection
75%
Mitogen Activated Protein Kinase Inhibitor
75%
Mitogen Activated Protein Kinase P38 Inhibitor
50%
Antiparasitic Activity
25%
Toxoplasma
25%
Encephalitozoon Cuniculi
25%
Mitogen Activated Protein Kinase
25%
Pyrimethamine
25%
SB 203580
25%
Sulfadiazine
25%
4 (4 Fluorophenyl) 2 (4 Hydroxyphenyl) 5 (4 Pyridyl)imidazole
25%
Microsporidia
25%
Drug Action
25%
Immunology and Microbiology
Mitogen
100%
Encephalitozoon Cuniculi
100%
Toxoplasma gondii
100%
Mouse
44%
Inoculum
11%
Fibroblast
11%
Drug Mechanism
11%
Intracellular Parasite
11%
Toxoplasma
11%
Microsporidia
11%
Immunosuppression
11%
Pyrimethamine
11%